C. Holmes

Physiology · Nature Genetics · 2003–2019

A researcher in the Science corpus: 16 papers; trusts 4 researchers and is trusted by 7 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 98 citations into it; #301 of 2,276 by trust here, #49 by citations
• Neurology — 83 citations into it; #253 of 1,455 by trust here, #152 by citations
• Immunology — 54 citations into it; #878 of 2,160 by trust here, #949 by citations

Whom C. Holmes trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. C. Cunningham

Who trusts C. Holmes overall

1. C. Cunningham
2. A. Varatharaj
3. R. Ransohoff
4. V. Perry
5. I. Galea
6. J. Burda
7. John Hardy
8. Wen-Ying Wang

Papers from C. Holmes's perspective

Ordered by how strongly the researchers C. Holmes trusts endorse each paper. Same corpus, a different order for every researcher.

1. Alternative activation of macrophages (Nature reviews. Immunology)
2. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration (Journal of Neuroscience)
3. The inflammatory reflex (Nature)
4. Siglecs and their roles in the immune system (Nature reviews. Immunology)
5. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. (European Journal of Pharmacology)
6. Delirium Superimposed on Dementia: A Systematic Review (Journal of The American Geriatrics Society)
7. Neuropathological stageing of Alzheimer-related changes
8. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics (Science)
9. Alzheimer's disease. (Cold Spring Harbor Perspectives in Biology)
10. Abundant Quantitative Trait Loci Exist for DNA Methylation and Gene Expression in Human Brain (PLoS Genetics)

Their papers

• Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease (2013) — 4,257 citations
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report (2003) — 1,464 citations
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease, and shows evidence for additional susceptibility genes (2009) — 1,794 citations
• Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease (2009) — 1,585 citations
• Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
• Microglial priming in neurodegenerative disease (2014) — 1,068 citations
• Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease (2014) — 1,239 citations
• Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2013) — 1,348 citations
• Donepezil and memantine for moderate-to-severe Alzheimer's disease. (2012) — 671 citations
• Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease (2011) — 1,932 citations
• Microglia in neurodegenerative disease (2010) — 1,554 citations
• Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease (2010) — 635 citations
• Systemic inflammation and disease progression in Alzheimer disease (2009) — 1,051 citations
• Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. (2008) — 1,443 citations
• The Montreal Cognitive Assessment: Validity and Utility in a Memory Clinic Setting (2007) — 652 citations
• Systemic infections and inflammation affect chronic neurodegeneration (2007) — 1,027 citations